PACS director granted 4,287 RSUs in stock award

Dilsaver Evelyn S reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Dilsaver Evelyn S reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. director Evelyn S. Dilsaver received an equity award in the form of 4,287 shares of Common Stock as a grant, reported at a price of $0.00 per share, indicating compensation rather than a market purchase. This award is structured as restricted stock units (RSUs), each convertible into one share of Common Stock upon vesting. All of the RSUs will vest on the earlier of July 1, 2027 or the date of the next annual meeting following the grant, assuming she continues to serve the company. After this grant, her directly held position reported in this filing is 36,085 shares of Common Stock.

Insights

Equity Compensation Analyst

Routine RSU grant to PACS director with time-based vesting.

The filing shows director Evelyn S. Dilsaver receiving 4,287 RSUs of PACS Group, Inc. Each RSU converts into one share of Common Stock at vesting, with no cash paid by the director, reflecting standard board compensation.

The RSUs vest 100% on the earlier of July 1, 2027 or the next annual meeting date, contingent on continued service. This time-based vesting encourages ongoing board engagement rather than signaling a market view like an open-market stock purchase would.

Following the grant, her reported direct holdings total 36,085 shares of Common Stock. As a non-cash, service-based award with no concurrent sales or derivative exercises, this appears to be a routine governance and compensation event rather than a directional trading signal.

Insider Trade Summary

Grant/Award: 4,287 shares

Grant/Award 1 txn

Insider Dilsaver Evelyn S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,287	$0.00	$0.00

Holdings After Transaction: Common Stock — 36,085 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer.

Key Figures

RSU grant size: 4,287 shares Grant price: $0.00 per share Shares after transaction: 36,085 shares +1 more

4 metrics

RSU grant size 4,287 shares Restricted stock units granted to director on July 1, 2026

Grant price $0.00 per share Reported transaction price for RSU grant

Shares after transaction 36,085 shares Director’s direct Common Stock holdings post-grant

RSU vesting date July 1, 2027 100% vesting or earlier at next annual meeting

Key Terms

restricted stock units ("RSUs"), vesting, annual meeting, Common Stock

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vesting financial

"one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

annual meeting financial

"will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

Common Stock financial

"one (1) share of Common Stock for each RSU upon vesting"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PACS director Evelyn S. Dilsaver report?

Evelyn S. Dilsaver reported receiving a grant of 4,287 restricted stock units in PACS Group, Inc. These RSUs are compensation-based awards that convert into Common Stock upon vesting, rather than an open-market stock purchase or sale, and therefore represent equity compensation, not trading activity.

How many PACS Group (PACS) shares does Evelyn S. Dilsaver hold after this grant?

After the reported equity grant, Evelyn S. Dilsaver holds 36,085 shares of PACS Group Common Stock directly. This figure includes the impact of the 4,287-share RSU award disclosed in the filing and represents her post-transaction position as reported on the Form 4.

When do Evelyn S. Dilsaver’s PACS restricted stock units vest?

All 4,287 restricted stock units vest on the earlier of July 1, 2027 or the date of the next annual meeting after the grant. Vesting is conditioned on her continued service to PACS Group, meaning she must remain a director through that vesting date.

Did Evelyn S. Dilsaver buy PACS (PACS) stock on the open market?

No, the filing shows a grant of 4,287 RSUs at a reported price of $0.00 per share. This indicates an equity award as compensation, not an open-market stock purchase, and does not reflect a cash outlay to acquire the shares.

What does the RSU grant mean for PACS Group’s insider ownership?

The RSU grant modestly increases director Evelyn S. Dilsaver’s equity exposure to PACS Group to 36,085 shares. Because this is a standard board compensation award with time-based vesting, it mainly reinforces alignment with shareholders rather than signaling a change in insider sentiment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dilsaver Evelyn S

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		4,287(1)	A	$0	36,085	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)